Ferring Announces U.S. FDA Advisory Committee Meeting for SI-6603 (condoliase), An ...
Ferring Announces U.S. FDA Advisory Committee Meeting for SI-6603 (condoliase), An Investigational Treatment in Lumbar Disc ...
Le Lézard6 小时
Johnson & Johnson seeks U.S. FDA approval for first pediatric indications for TREMFYA ...
Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA® (guselkumab) for ...